rs6537296

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000649263.1(ENSG00000285713):​n.328-150804T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 152,058 control chromosomes in the GnomAD database, including 10,773 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10773 hom., cov: 32)

Consequence

ENSG00000285713
ENST00000649263.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.309

Publications

13 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000649263.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000649263.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000285713
ENST00000649263.1
n.328-150804T>C
intron
N/AENSP00000497507.1A0A3B3ISY7
ENSG00000285783
ENST00000650526.1
n.223-150804T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.367
AC:
55805
AN:
151940
Hom.:
10765
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.262
Gnomad AMI
AF:
0.394
Gnomad AMR
AF:
0.320
Gnomad ASJ
AF:
0.362
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.491
Gnomad FIN
AF:
0.536
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.413
Gnomad OTH
AF:
0.340
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.367
AC:
55821
AN:
152058
Hom.:
10773
Cov.:
32
AF XY:
0.373
AC XY:
27689
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.261
AC:
10845
AN:
41500
American (AMR)
AF:
0.321
AC:
4904
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
1257
AN:
3472
East Asian (EAS)
AF:
0.301
AC:
1557
AN:
5180
South Asian (SAS)
AF:
0.492
AC:
2370
AN:
4816
European-Finnish (FIN)
AF:
0.536
AC:
5641
AN:
10528
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.413
AC:
28060
AN:
67956
Other (OTH)
AF:
0.339
AC:
716
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1805
3611
5416
7222
9027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.406
Hom.:
1661
Bravo
AF:
0.339
Asia WGS
AF:
0.367
AC:
1277
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.80
DANN
Benign
0.55
PhyloP100
0.31

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6537296;
hg19: chr4-145487934;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.